Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions

Critical Care

Volumn 20, Issue 1, 2016, Pages

  León, Cristóbal ^a   Ruiz Santana, Sergio ^b   Saavedra, Pedro ^c   Castro, Carmen ^a   Loza, Ana ^a   Zakariya, Ismail ^a   Úbeda, Alejandro ^d   Parra, Manuel ^a   Macías, Desirée ^a   Tomás, José Ignacio ^e   Rezusta, Antonio ^e   Rodríguez, Alejandro ^f   Gómez, Frederic ^f   Martín Mazuelos, Estrella ^a   Tomas J I ^e   Gurpegui, M ^e   Gonzalez V ^e   Leon C ^a   ubeda A ^a   Macias D ^a   Rodriguez A ^f   Bodi, M ^f   Gomez F ^f   Trefler, S ^f   Llaurado M ^f   Guell R ^f   Gonzalez R ^g   Diaz F J ^g   González, Raúl ^g   Marcos, J M ^g   Carriedo, D ^g   Fernandez I ^g   Valverde, E ^g   Esteban, A ^g   Marrodan, T ^g   Arenzana, A ^h   Gonzalez C ^h   Suarez A I ^h   Ballus J ⁱ   Esteve, F ⁱ   Ayats, J ⁱ   Aguilar, G ^j   Badenes, R ^j   Ferrando, C ^j   Navarro, D ^j   Carbonell, J A ^j   Garcia C ^j   Gomez A ^j   Henao, L ^j   Minana A ^j   Puig, J ^j   Belda, F J ^j   Puppo, A ^k   Garnacho, J ^k   Marquez J A ^k   Gutierrez A ^k   Ruiz, M ^k   Jerez V ^l   Trasmonte, V ^l   Martinez P ^l   Perez D ^l   Fajardo, M ^l   Gaona, C ^l   Munoz C ^l   Tamayo, G ^m   Martinez A ^m   Labayen, F ^m   Iruretagoyena, J R ^m   Lopez L ^m   Hernandez J L ^m   Hernandez M A ^b   Bordes, A ^b   Ojeda, N ^b   Jimenez J D ⁿ   more..

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d HOSPITAL PUNTA DE EUROPA   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^g Gerencia Regional de Salud de Castilla y León   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

ⁱ HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l HOSPITAL INFANTA CRISTINA   (Spain)

^m HOSPITAL DE CRUCES   (Spain)

ⁿ HOSPITAL DON BENITO VILLANUEVA   (Spain)

more..

Author keywords

(1 3) D glucan; Anti mannan antibody; Candida albicans germ tube antibody; Candida PCR; Candida spp. colonization; Candidemia; Intra abdominal candidiasis; Invasive candidiasis; Mannan antigen

Indexed keywords

ANTIFUNGAL AGENT; BETA GLUCAN; CANDIDA ALBICANS GERM TUBE ANTIBODY; CARBOHYDRATE ANTIGEN; FUNGAL DNA; FUNGUS ANTIBODY; MANNAN ANTIBODY; MANNAN ANTIGEN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MANNAN;

ABDOMINAL DISEASE; AGED; ARTICLE; BLOOD SAMPLING; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEYEROZYMA GUILLIERMONDII; MULTIPLEX POLYMERASE CHAIN REACTION; PICHIA KUDRIAVZEVII; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BLOOD; CANDIDIASIS, INVASIVE; CRITICAL ILLNESS; IMMUNOLOGY; MIDDLE AGED; MORTALITY; NURSING; PATHOGENICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; BIOMARKERS; CANDIDA ALBICANS; CANDIDIASIS, INVASIVE; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MANNANS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 85008600459     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/S13054-016-1324-3     Document Type: Article

References (38)

1. León C, Ostrosky-Zeichner L, Schuster M. What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med. 2014;40:808-9.
2. Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff L, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med. 2014;40:1303-12.
3. Colombo AL, Guimaraes T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med. 2014;40:1489-98.
4. Maubon D, Garnaud C, Calandra T, Sanglard D, Cornet M. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med. 2014;40:1241-55.
5. Shields RK, Nguyen MH, Clancy CJ. Clinical perspectives on echinocandin resistance among Candida species. Curr Opin Infect Dis. 2015;28:514-22.
6. Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445-6.
7. Clancy CJ, Nguyen MH. Finding the "missing 50 %" of invasive candidiasis: how non-culture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56:1284-92.
8. Mikulska M, Furfaro E, Viscoli C. Non-cultural methods for the diagnosis of invasive fungal disease. Expert Rev Anti Infect Ther. 2015;12:103-17.
9. Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27:490-526.
10. Clancy CL, Nguyen MH. Undiagnosed invasive candidiasis: incorporating non-culture diagnostics in to rational prophylactic and preemptive antifungal strategies. Expert Rev Anti Infect Therap. 2014;12:731-4.
11. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J. Alvarez-Lerma F, et al. A bedside scoring system ("Candida score") for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730-7.
12. León C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C, et al. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37:1624-33.
13. Fortun J, Meije Y, Buitrago MJ, Gago S, Bernal-Martínez L, Pemán J, et al. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother. 2014;69:3134-41.
14. Pittet D, Monod M, Suter PM, Frenk E, Auckentaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220:751-8.
15. Basseti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, et al. A research agenda on the management of intraabdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39:2092-106.
16. R Development Core Team. A language and environment for statistical computing. Vienna, Austria: Foundation for Statistical Computing. http://www.r-project.org/.
17. Olaechea-Astigarraga PM. Alvarez-Lerma F, Palomar-Martinez M, Insausti-Ordeñana J, Lopez-Pueyo MJ, Seijas-Betolaza I, et al. Evolución del consumo de antifúngicos en pacientes críticos. Estudio multicéntrico observacional 2006-2010. Enferm Infecc Microbiol Clin. 2012;30:435-40.
18. Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, et al. Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med. 2012;40:813-22.
19. Ruhnke M. Antifungal stewardship in invasive Candida infections. Clin Microbiol Infect. 2014;20 Suppl 6:11-8.
20. Muñoz P, Valerio M, Antonio Vena A, Bouza E. Antifungal stewardship in daily practice and health economic implications. Mycoses. 2015;58 Suppl 2:14-25.
21. León C, Ruiz-Santana S, Saavedra P, Castro C, Ubeda A, Loza A, et al. Value of (1→3) β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med. 2012;38:1315-25.
22. Martín-Mazuelos E, Loza A, Castro C, Macías D, Zakariya I, Saavedra P, et al. β-D-glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis. Intensive Care Med. 2015;41:1424-32.
23. Ellis M, Al-Ramadi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H, et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol. 2008;57:287-95.
24. Hanson KE, Pfeiffer CD, Lease ED, Balch AH, Zaas AK, Perfect JR, et al. (1,3)-b-D-Glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study. PLoS One. 2012;7:e42282.
25. Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, et al. Difficulties in using (1,3)-b-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis. J Med Microbiol. 2010;59:1016-22.
26. Tissot F, Lamoth F, Hauser PM, Orasch C, Fluckiger U, Siegemund M, et al. Betaglucan antigenemia anticipates diagnosis of blood culture negative intra-abdominal candidiasis. Am J Respir Crit Care Med. 2013;188:1100-9.
27. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-22.
28. Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect. 2012;18 Suppl 7:9-18.
29. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165-228.
30. Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, et al. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data. Intensive Care Med. 2015;41:1931-40.
31. Martínez-Jiménez MC, Muñoz P, Guinea J, Valerio M, Alonso R, Escribano P, et al. Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia. Med Mycol. 2014;52:270-5.
32. Martinez-Jimenez MC, Muñoz P, Valerio M, Alonso R, Martos C, et al. Candida biomarkers in patients with candidaemia and bacteraemia. J Antimicrob Chemother. 2015;70:2354-61.
33. Martínez-Jiménez MC, Muñoz P, Valerio M, Vena A, Guinea J, Bouza E. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment. J Antimicrob Chemother. 2015;70:3107-15.
34. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C, Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14:R222.
35. Chumpitazi BF, Lebeau B, Faure-Cognet O, Hamidfar-Roy R, Timsit JF, Pavese P, et al. Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis. Med Mycol. 2014;52:462-71.
36. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011;49:665-70.
37. Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, et al. Performance of Candida real-time polymerase chain reaction, beta-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis. 2012;54:1240-8.
38. Held J, Kohlberger I, Rappold E, Grawitz AB, Hackera G. Comparison of (1-3)-b-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol. 2013;51:1158-64.